The Global Biopharmaceuticals Market is expected to reach $526 Billion by 2026; with a CAGR of 13.8% from 2019 to 2026. North America accounts for the largest market share in the year 2018, driven by increased investment into research & development and advancement in technology. The Asia-Pacific shows immense potential for the biopharmaceuticals market in the coming years, owing to its extensive usage in the pharmaceutical industry.
The major applications of biopharmaceuticals in chronic diseases like cancer, and HIV/Aids are the key drivers impacting the overall growth of this market. Rapid use of biopharmaceuticals to recover various diseases is also propelling the market. However, the cost of initial investments in the biopharmaceuticals along with the less chances of success of those products may hamper the market. The increasing awareness in the diseases treatment and disease recovery has the major chances of growth in this market.
The global biopharmaceuticals market is segmented into application, type, product, and geography. The application segment is divided into metabolic disorders, cardiovascular disorders, immunology, a blood disorder, and others. The type segment is classified into hormone, insulin, monoclonal antibody, and others. The Product segment is classified into conventional vaccines, recombinant enzymes, recombinant vaccines & others. The geography segment is classified into North America, Europe, Asia-Pacific, and Rest of the World.
The country-wise analysis has been also covered under the scope of the report. North America covers the U.S., Canada, and Mexico while Europe covers Germany, France, Italy, U.K., and Rest of Europe. Japan, China, India, Australia, and Rest of Asia-Pacific have been analyzed under the Asia-Pacific market. Rest of the world includes Central America, South America, the Middle East, and Africa.
The scope of the report covers in-depth analysis of the market in terms of both qualitative and quantitative analysis across the segments as well as cross-sectional analysis of the segments including the geographies and its countries. The market has been analyzed both from demand as well as supply side to come to an accurate scenario. Products across application and application across geographies have been mapped to provide you a precise competitive scenario to have a leading edge in the market.
Key companies operating in this market and their company profile along with the market share analysis and competitive scenario is also part of the report. Top players are Pfizer Inc., Abbott Laboratories, Merck & Co., Johnson & Johnson, Biogen, Amgen Inc., Novartis AG, Bayer AG, Sanofi, F. Hoffmann-La Roche Ltd, and others.
The Highlights of the Report
Scope of the Global Biopharmaceuticals Market